QuantuMDx

QuantuMDx builds rapid point of care PCR diagnostic devices.

Newcastle upon Tyne, UK—Founded 2008—Website

£26.0MTotal raised

QuantuMDx develops molecular point of care diagnostic solutions designed to empower disease control and pathogen identification. The company operates globally with strategic partnerships across multiple continents.

Founders

Jonathan O’Halloran

Co-founder and Chief Executive

Investors

Series B8 November 2021
£15.0M
VS
Vita Spring
Series B24 March 2021
£11.0M
British Business Bank
Future Fund

Funding history

Series B8 November 2021

£15.0M

QuantuMDx secures £15m Series B follow-on investment from Vita Spring to develop diagnostic platforms.

Vita Spring provided the funding as QuantuMDx also pursues commercialisation discussions with Sansure Biotech.

Series B24 March 2021

£11.0M

QuantuMDx Group raises £11m Series B from the British Business Bank to scale manufacturing

The company secured an £11m convertible loan to scale manufacturing and commercial operations for its point-of-care diagnostic system.